Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abbey Pharmaceuticals
London, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Abbey Pharmaceuticals was a specialty biotechnology company focused on the development of innovative therapies for respiratory diseases, specifically respiratory syncytial virus (RSV). Founded by a team of former MedImmune executives, the company's primary focus was advancing a next-generation monoclonal antibody designed to prevent RSV infections in high-risk infants. This lead candidate was intended to build upon the clinical and commercial success of palivizumab (Synagis) by offering improved potency and dosing profiles. In April 2011, Abbey Pharmaceuticals was acquired by MedImmune, the global biologics division of AstraZeneca, to bolster its infectious disease pipeline. Following the acquisition, Abbey's assets and expertise were integrated into AstraZeneca's broader respiratory and biologics research and development programs.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Monoclonal antibody
- Industry
- Biotech
Beyond the preview
Go deeper on Abbey Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abbey Pharmaceuticals.